Gastric Fistula After MR-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Applied Radiation Oncology · 2023
DOI: 10.37549/aro-d-23-00014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Radiation Oncology, 2023. Verfasst von Sarah Goodchild und 4 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Integration of locoregional therapies such as stereotactic body radiation therapy (SBRT) is increasing in the treatment of hepatocellular carcinoma (HCC), the most common primary cancer of the liver. A 68-year-old man with hepatitis C was diagnosed with American Joint Committee on Cancer stage 2 (cT2N0M0), Child-Pugh class A, multifocal HCC. He completed adaptive MR-guided stereotactic body radiation therapy (MRgSBRT) for a total dose of 50 Gy in 5 fractions. At the 3-month follow-up, a three-phase abdominal CT showed a decrease in the size of the treated lesion and a new gastric fistula was noted. He started a proton pump inhibitor and remained under close observation. At the 6-month follow-up, imaging showed a decrease in tumor size with continued evidence of a contained fistula. Severe side effects are possible following MRgSBRT to the liver, even with the utilization of adaptive treatment, highlighting the importance of attention to high-dose isodose lines near normal tissues and adherence to dose constraints.
Zitieren
APA
Goodchild, S., Mills, M. N., Palm, R. F., Hoffe, S. E., & Frakes, J. M. (2023). Gastric Fistula After MR-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Applied Radiation Oncology. https://doi.org/10.37549/aro-d-23-00014
Vancouver
Goodchild S, Mills MN, Palm RF, Hoffe SE, Frakes JM. Gastric Fistula After MR-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Applied Radiation Oncology. 2023. doi:10.37549/aro-d-23-00014
BibTeX
@article{Goodchild2023,
author = {Goodchild, Sarah and Mills, Matthew N. and Palm, Russell F. and Hoffe, Sarah E. and Frakes, Jessica M.},
title = {Gastric Fistula After MR-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma},
journal = {Applied Radiation Oncology},
year = {2023},
doi = {10.37549/aro-d-23-00014}
}
EUVIMED